Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25240821

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Oct
First author
Wilke H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Oct;15(11):1182-4. doi: 10.1016/S1470-2045(14)70464-4.
    note
    Source null
    related pmid
    25240820
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2015 Jan;12(1):7-8. doi: 10.1038/nrclinonc.2014.195.
    note
    Source null
    related pmid
    25403941
    relationship
    Comment in

Authors and identifiers

  1. name
    Wilke H
    type
    Author
  2. name
    Muro K
    type
    Author
  3. name
    Van Cutsem E
    type
    Author
  4. name
    Oh SC
    type
    Author
  5. name
    Bodoky G
    type
    Author
  6. name
    Shimada Y
    type
    Author
  7. name
    Hironaka S
    type
    Author
  8. name
    Sugimoto N
    type
    Author
  9. name
    Lipatov O
    type
    Author
  10. name
    Kim TY
    type
    Author
  11. name
    Cunningham D
    type
    Author
  12. name
    Rougier P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wilke H
    type
    Author
  2. name
    Muro K
    type
    Author
  3. name
    Van Cutsem E
    type
    Author
  4. name
    Oh SC
    type
    Author
  5. name
    Bodoky G
    type
    Author
  6. name
    Shimada Y
    type
    Author
  7. name
    Hironaka S
    type
    Author
  8. name
    Sugimoto N
    type
    Author
  9. name
    Lipatov O
    type
    Author
  10. name
    Kim TY
    type
    Author
  11. name
    Cunningham D
    type
    Author
  12. name
    Rougier P
    type
    Author
bibliography ids
  1. nci-bib-a100047dac5f564468e29a68
book metadata
content sha256
03ccdafdbdbb982802af8405e3cc060d082d2915008a0b48707ddf79b69f02cc
document type
citation
dois
  1. 10.1016/S1470-2045(14)70420-6
electronic publication date
display
2014 Sep 17
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25240821
immutable id
pubmed:25240821@03ccdafdbdbb982802af8405e3cc060d082d2915008a0b48707ddf79b69f02cc
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1224-35
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Oct;15(11):1182-4. doi: 10.1016/S1470-2045(14)70464-4.
    note
    Source null
    related pmid
    25240820
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2015 Jan;12(1):7-8. doi: 10.1038/nrclinonc.2014.195.
    note
    Source null
    related pmid
    25403941
    relationship
    Comment in
outcomes validated
false
pmid
25240821
provenance
batch id
69903be8ceab8801c81a
provider
NCBI PubMed ESummary
record sha256
aac22073648ca214cbbf600f7ce7ce4a7b8a3edf7c973e65b69e0974b57d62ce
response sha256
1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
retrieved at
2026-09-09T23:47:05.208886+00:00
publication date
display
2014 Oct
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25240821/
title
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.

Preserved source evidence · Not medical advice